Product successfully added to your shopping cart
Quantity
Total
There are 1 items in your cart. There is 1 item in your cart.
Total products (tax excl.) 395,00 €
Total shipping (tax excl.) To be determined
Total (tax excl.) 395,00 €
Data sheet of FOXC2 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Goat |
| Applications | ELISA,WB-Ti,IHC-P |
More info about FOXC2 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB6426 |
| Product name: | FOXC2 polyclonal antibody |
| Product description: | Goat polyclonal antibody raised against synthetic peptide of FOXC2. |
| Gene id: | 2303 |
| Gene name: | FOXC2 |
| Gene alias: | FKHL14|LD|MFH-1|MFH1 |
| Gene description: | forkhead box C2 (MFH-1, mesenchyme forkhead 1) |
| Immunogen: | A synthetic peptide corresponding to C-terminus of human FOXC2. |
| Immunogen sequence/protein sequence: | RHAAPYSYDCTKY |
| Protein accession: | NP_005242.1 |
| Form: | Liquid |
| Concentration: | 0.5 mg/mL |
| Recommend dilutions: | ELISA (1:8000) Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (2-4 ug/mL) Western Blot (1-3 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In Tris saline, pH 7.3 (0.5% BSA, 0.02% sodium azide) |
| Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Goat |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | FOXC2 polyclonal antibody (Cat # PAB6426) staining (1 ug/mL) of human breast cancer lysate (RIPA buffer, 30 ug total protein per lane). Primary incubated for 1 hour. Detected by western blot using chemiluminescence. |
| Applications: | ELISA,WB-Ti,IHC-P |
| Shipping condition: | Dry Ice |
| Publications: | Foxc2 is expressed in developing lymphatic vessels and other tissues associated with lymphedema-distichiasis syndrome.Dagenais SL, Hartsough RL, Erickson RP, Witte MH, Butler MG, Glover TW. Gene Expr Patterns. 2004 Oct;4(6):611-9. |